Form 4: Indivior Pharmaceuticals Director Receives Stock Grant

Indivior Pharmaceuticals, Inc. reports a grant of Restricted Stock Units to Director Barbara Ryan.

Summary

• Director Barbara Ryan was granted 6,518 Restricted Stock Units (RSUs) on May 13, 2026.
• Each RSU represents a contingent right to receive one share of Indivior Pharmaceuticals' common stock.
• These RSUs are subject to vesting on the day before the annual stockholders' meeting following the grant date, contingent on continued service.
• Following this grant, Barbara Ryan beneficially owns 12,242 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation event for a director rather than a significant financial or strategic development for the company.

Positives

• Grant of 6,518 RSUs to Director Barbara Ryan, indicating continued investment and incentive for leadership.
• The grant vests based on continued service, aligning the director's interests with the company's long-term performance.

Risks

• The RSUs are subject to vesting conditions, meaning they may not be fully realized if the reporting person's service is terminated before the vesting date.

Future Outlook

The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Industry Context

StockSavvy.ai notes that grants of Restricted Stock Units to directors are a common practice in the pharmaceutical industry to incentivize long-term commitment and align executive interests with shareholder value.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director aligns their interests with long-term company performance, potentially benefiting shareholders.

Next Steps

• Vesting of RSUs on the day preceding the annual stockholders' meeting, contingent on continued service.

Key Dates

Keywords

Indivior Pharmaceuticals, INDV, Form 4, Stock Grant, Restricted Stock Units, RSU, Director Compensation, Beneficial Ownership, SEC Filing